🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07326358
Recruiting Observational

AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study

NCT07326358 · tracked via the Priya Life Science China tracker
Sponsor
Ruijin Hospital
Phase
Observational
Started
2025-12-12
Last updated
2026-01-08

Condition(s) studied

Nasopharyngeal NeoplasmsLaryngeal Disease

Investigational drug(s) / intervention(s)

DiagnosticDiagnostic

Diagnostic: The deep learning model is trained using the training dataset and tested with the internal validation set.

Diagnostic: The prospective dataset is used for the comparative testing of the model and physicians.

Study summary

An artificial intelligence-assisted system is trained and validated by collecting nasopharyngolaryngoscopy images from patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years; * Underwent standard electronic nasopharyngolaryngoscopy; * Patients who underwent biopsy sampling have a clear pathological diagnosis; * Signed a written informed consent form. Exclusion Criteria: * Image quality is substandard with severe motion artifacts; * Lesion images are unclear and incomplete.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China Recruiting

More Ruijin Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07326358 on ClinicalTrials.gov ↗ ← All trials in China